≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_FIBROSARCOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C47.5|C48.5|C49.5
  • Cause of death: ICD-10 — C47.5|C48.5|C49.5
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 8810|8811|8814|8815|8821|8830|8832|8840
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

299

4. Check minimum number of events

None

299

5. Include endpoints

None

299

6. Filter based on genotype QC (FinnGen only)

299

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Fibrosarcoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 299 145 154
Unadjusted period prevalence (%) 0.06 0.05 0.07
Median age at first event (years) 53.27 52.77 53.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
230
Matched controls
2300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
47.6
44
*
8832/3-C44.5
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of trunk
+∞
44.2
41
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.8
22.5
61
115
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
22.2
21
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
22.2
21
*
H02AB02
ATC
dexamethasone; systemic
24.3
20.1
28
13
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.4
19.5
37
38
WF003
NOMESCO Finland
Adjuvant radiotherapy
206.1
18.8
19
*
JN4BD
NOMESCO Finland
Extensive body CT
9.8
18.1
37
44
8832/3-C44.7
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of lower limb and hip
+∞
17.9
17
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
17.9
17
*
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
17.9
17
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
16.9
16
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
16.9
16
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
16.9
16
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
16.9
16
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
15.8
15
*
8832/3-C44.6
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of upper limb and shoulder
+∞
15.8
15
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
15.8
15
*
ZZR00
NOMESCO Finland
Flap of skin
34.3
15.1
19
6
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
27.2
15.0
20
8
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
159.7
14.6
15
*
ZZA00
NOMESCO Finland
Split skin graft
12.0
13.9
25
23
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
11.1
13.9
26
26
ZZR10
NOMESCO Finland
Flap of skin and muscle
80.0
13.7
15
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.7
13
*
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
13.7
13
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
13.7
13
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
14.3
12.7
21
16
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
12.6
12
*
8832/3-C44.9
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin, NOS
+∞
12.6
12
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
12.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
39.9
12.4
15
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
19.4
12.3
18
10
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
12.2
75
298
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
49.4
12.0
14
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
11.6
11
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
11.6
11
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
11.6
11
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
11.6
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
11.6
11
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
10.3
10.5
20
21
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.5
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
9.1
10.3
21
25
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
14.2
9.8
16
12
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
11.4
9.5
17
16
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
9.4
9
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
9.4
9
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.4
9.0
23
39
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
8.8
113
670
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
8.8
69
314
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
8.6
25
50
WF002
NOMESCO Finland
Radical radiotherapy
93.3
8.5
9
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.4
8
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
8.4
8
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
8.4
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
12.3
8.2
14
12
HA1AA
NOMESCO Finland
X-ray mammography
10.6
8.2
15
15
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
10.6
8.2
15
15
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
23.0
8.1
11
5
A04AA01
ATC
ondansetron; systemic, rectal
10.6
7.6
14
14
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
26.0
7.6
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
7.4
46
181
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
7.3
7
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
7.3
7
*
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
+∞
7.3
7
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
+∞
7.3
7
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
7.4
7.1
16
23
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.2
6.9
20
41
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
17.3
6.8
10
6
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
41.3
6.8
8
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
41.3
6.8
8
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
8.2
6.7
14
18
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.6
6.6
22
52
JN4AD
NOMESCO Finland
Body CT examination
6.0
6.6
17
30
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
14.9
6.5
10
7
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.1
6.4
19
40
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
6.4
36
132
L02BG04
ATC
letrozole; oral
18.6
6.3
9
5
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
6.3
6
*
C49.45
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of abdominal fibrosarcoma
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
L02BA01
ATC
tamoxifen; oral
+∞
6.3
6
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
C49.59
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
66
58
14.32
66.09
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
143
669
3.18
21.36
2.7
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
56
147
4.46
20.00
1.5
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
13
10.41
11.41
1.4
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
151
969
2.13
9.33
4.0
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
120
3.27
8.93
4.2
1.5
ug/l
4.5
2.8
0.39
27
90
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
30
5.58
8.30
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
105
652
1.94
6.56
2.3
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
168
1220
1.86
6.41
11.8
6.5
e9/l
3.9
4.3
1.69
152
1057
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
9
11.44
5.83
2.1
1.4
ug/l
13.6
12.3
—
10
9
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
84
505
1.92
5.67
2.3
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
156
1138
1.78
5.59
9.5
3.8
umol/l
13.0
12.8
0.03
150
1063
(40768443) Skin Pathology biopsy report
24
86
2.95
5.28
1.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
215
1744
1.83
5.17
9.8
5.2
u/l
80.5
76.9
0.68
206
1587
(3032080) INR in Blood by Coagulation assay
131
935
1.71
4.87
6.1
9.9
inr
1.0
1.3
10.75
32
251
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
26
4.35
4.39
1.0
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
135
994
1.65
4.33
6.1
5.4
mmol/l
1.2
1.2
0.18
126
887
(3023368) Bacteria identified in Blood by Culture
89
588
1.73
4.28
4.4
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
103
722
1.65
3.92
6.0
5.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
136
1027
1.59
3.80
6.1
5.3
%
57.0
57.2
0.06
130
953
(3042936) Bacteria identified in Isolate by Culture
57
345
1.81
3.66
1.9
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
136
1037
1.57
3.59
6.4
5.6
%
27.4
28.0
0.22
130
960
(3019198) Lymphocytes [#/volume] in Blood
144
1119
1.55
3.46
6.3
5.4
e9/l
1.7
1.9
2.69
129
976
(3001604) Monocytes [#/volume] in Blood
141
1095
1.54
3.37
6.4
5.3
e9/l
0.6
0.6
0.63
127
936
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
141
1098
1.54
3.31
6.7
6.0
mmol/l
1.2
1.2
0.99
122
945
(3019069) Monocytes/100 leukocytes in Blood
132
1018
1.53
3.22
6.6
5.7
%
8.9
8.7
0.36
126
945
(3003396) Base excess in Arterial blood by calculation
44
257
1.83
3.16
5.2
6.2
mmol/l
0.9
1.7
0.71
34
204
(40758558) Short blood count panel - Blood
76
519
1.62
3.13
12.5
5.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
131
1014
1.52
3.11
6.4
5.4
%
3.0
2.9
0.21
125
936
(3006315) Basophils [#/volume] in Blood
140
1102
1.51
3.06
6.4
5.3
e9/l
0.0
0.0
0.15
125
947
(3022096) Basophils/100 leukocytes in Blood
127
987
1.50
2.91
6.5
5.4
%
0.7
0.7
0.85
121
909
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
53
2.72
2.83
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
53
2.72
2.83
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
14
5.09
2.74
1.0
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
142
1140
1.47
2.72
6.6
5.6
e9/l
0.2
0.2
0.29
126
1000
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
31
174
1.87
2.54
2.8
2.0
g/l
0.2
0.2
0.11
31
154
(3013826) Glucose [Moles/volume] in Serum or Plasma
165
1377
1.44
2.51
4.1
4.1
mmol/l
6.5
6.8
1.72
159
1284
(3042631) Mycobacterium sp identified in Specimen
8
21
3.88
2.48
1.8
3.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
40
2.82
2.40
1.5
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
26
142
1.91
2.32
2.8
4.2
%
0.1
0.0
—
10
27
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
18
3.95
2.26
1.9
4.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
151
1.87
2.25
2.9
4.1
%
1.1
0.8
0.24
11
32
(3025159) Blasts/100 leukocytes in Blood
25
138
1.89
2.17
2.9
4.3
%
0.0
0.0
—
9
24
(3014576) Chloride [Moles/volume] in Serum or Plasma
43
281
1.62
2.10
4.2
5.8
mmol/l
105.1
104.1
1.11
43
269
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
365
1.55
2.08
1.8
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
32
2.87
2.01
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
32
2.87
2.01
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
85
650
1.43
2.00
5.1
3.2
ph
7.4
7.4
0.17
22
106
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
11
4.60
1.95
4.8
1.8
nmol/l
2.8
4.8
—
5
11
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
246
1.62
1.93
3.1
2.3
umol/l
13.5
9.3
0.36
32
214
(3021589) Normoblasts [#/volume] in Blood
119
970
1.38
1.92
11.5
8.1
e9/l
0.0
0.0
0.40
106
778
(3002179) Metamyelocytes/100 leukocytes in Blood
24
137
1.82
1.90
3.0
4.2
%
0.8
0.3
—
8
23
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
223
1.59
1.66
3.6
3.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
128
1.78
1.65
4.8
8.8
mmol/l
24.8
25.3
0.29
22
128
(3013707) Erythrocyte sedimentation rate by Westergren method
193
1726
1.33
1.58
3.6
4.1
mm/h
11.3
12.0
0.32
174
1582
(3003694) ABO and Rh group [Type] in Blood
68
521
1.40
1.56
1.4
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
89
715
1.35
1.53
6.8
2.1
mmol/l
2.4
2.4
0.07
78
599
(3026389) Candida sp identified in Specimen by Organism specific culture
7
27
2.63
1.52
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
262
1.52
1.51
2.1
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
37
2.48
1.49
1.9
3.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
37
2.48
1.49
1.3
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
110
1.78
1.46
6.7
8.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
85
683
1.34
1.45
2.5
3.0
e6/l
70.1
136.7
0.27
69
526
(3004809) Band form neutrophils/100 leukocytes in Blood
6
22
2.76
1.44
1.8
4.2
%
0.7
0.6
—
6
16
(3013512) EKG study
86
695
1.33
1.41
3.7
4.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
266
1.49
1.41
1.6
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
61
468
1.38
1.39
4.4
4.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
248
2321
1.40
1.39
17.4
12.8
mg/l
24.1
24.0
0.02
203
1794
(40761511) CBC panel - Blood by Automated count
257
2425
1.43
1.32
15.2
12.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
69
1.92
1.30
2.5
3.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
138
1.64
1.30
1.4
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51
385
1.39
1.28
2.6
2.6
e6/l
0.6
1.1
1.20
32
217
(3022145) Colonoscopy Study observation
32
221
1.50
1.28
1.6
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
264
1.46
1.26
2.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
183
1653
1.28
1.25
3.5
3.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
38
2.13
1.19
1.8
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
28
191
1.51
1.19
5.2
6.2
mmol/l
1.3
1.4
0.21
28
182
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
208
2232
0.78
1.19
5.9
6.1
mmol/mol
39.6
40.4
0.96
193
2068
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
20
127
1.62
1.14
6.0
8.3
%
0.7
0.7
0.19
20
127
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
164
0.53
1.12
3.2
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
128
1.60
1.11
1.6
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
31
2.29
1.11
1.0
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
161
1.53
1.10
3.7
4.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
76
624
1.29
1.10
2.6
2.8
e6/l
0.6
0.5
0.22
63
462
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
46
1.99
1.04
1.1
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
398
0.70
1.03
1.3
1.3
iu/ml
21.3
34.2
—
5
134
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
34
2.08
1.03
2.6
3.4
e9/l
3.3
5.0
—
7
34
(3026782) Osmolality of Urine
55
437
1.32
1.02
2.1
2.5
mosm/kgh2o
568.3
542.7
0.38
49
358
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
35
2.02
1.00
2.7
3.9
%
56.6
60.7
—
7
35
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
171
1559
1.23
0.97
3.4
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
24
167
1.48
0.95
4.6
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
71
596
1.25
0.86
2.7
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
92
797
1.22
0.84
2.7
3.5
e6/l
479.6
77.6
0.54
71
566
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
19
130
1.49
0.83
6.4
8.2
%
1.3
1.5
0.51
19
130
(3045414) Leukocytes [Presence] in Urine
14
89
1.60
0.82
2.0
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
21
147
1.46
0.82
2.7
2.8
e9/l
3.7
4.1
0.35
15
112
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
359
1.30
0.82
2.6
2.9
e6/l
1.2
2.3
0.71
25
192
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
58
1.75
0.80
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.5
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
476
0.77
0.77
1.9
1.7
nmol/l
1193.7
1232.9
0.09
29
369
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
75
1.63
0.76
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
75
1.63
0.76
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
54
1.69
0.75
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
60
1.69
0.73
2.9
4.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
60
1.69
0.73
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
25
186
1.38
0.73
6.0
6.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
143
1306
1.18
0.73
2.5
2.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
76
1.60
0.73
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
142
0.62
0.71
3.1
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
248
0.71
0.69
1.7
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
44
531
0.80
0.67
1.4
1.7
pmol/l
467.3
431.5
0.24
36
431
(3025941) Bacteria identified in Stool by Culture
16
112
1.45
0.65
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
82
722
1.19
0.63
2.4
2.1
u/l
60.5
56.2
0.31
75
667
(21494755) Public health laboratory ask at order entry panel
14
198
0.69
0.62
1.3
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
56
476
1.22
0.62
1.9
2.2
e6/l
3.9
5.8
1.21
50
407
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
139
1.39
0.62
1.7
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
25
319
0.76
0.60
1.4
1.3
titre
905.0
506.2
—
8
78
(3001122) Ferritin [Mass/volume] in Serum or Plasma
105
948
1.17
0.60
2.5
2.6
ug/l
242.2
123.0
1.03
95
866
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
123
1.41
0.59
1.1
1.3
iu/ml
75.0
120.8
—
5
51
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
203
1.31
0.58
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
34
413
0.80
0.56
1.5
1.3
g/l
2.5
2.6
0.18
22
255
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
231
2393
0.85
0.54
4.5
5.2
mmol/l
2.7
2.7
0.20
209
2193
(3022313) Gas panel - Capillary blood
15
108
1.41
0.54
2.6
6.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
233
1.27
0.53
1.1
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
28
344
0.79
0.51
24.4
24.9
—
1.3
—
0
54
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
48
1.47
0.47
1.3
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
48
1.47
0.47
2.1
3.0
kpa
5.3
5.1
—
7
48
(3027315) Oxygen [Partial pressure] in Blood
7
48
1.47
0.47
2.1
3.0
kpa
8.3
8.2
—
7
48
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
40
468
0.83
0.47
1.3
1.2
u/ml
0.6
1.6
—
8
137
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
50
1.41
0.45
1.0
1.8
nmol/l
0.7
0.8
—
7
41
(3000330) Specific gravity of Urine by Test strip
16
121
1.34
0.45
3.1
3.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
89
810
1.14
0.45
3.0
3.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
286
1.21
0.44
2.3
2.3
%
19.4
23.7
1.28
29
253
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.6
1.4
pmol/l
162.4
63.0
—
5
31
(4010399)
21
167
1.28
0.43
1.3
1.5
—
—
—
0
0
(4034850)
6
93
0.64
0.43
4.2
9.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
56
1.44
0.43
7.3
4.3
mg/l
1.2
1.6
—
8
51
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
56
1.44
0.43
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
159
1504
1.12
0.43
3.3
3.0
u/l
44.4
45.8
0.12
152
1391
(3052851) Hemolysis interference index of Serum or Plasma
8
58
1.39
0.42
4.1
3.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
32
269
1.21
0.42
2.1
2.3
%
1.9
1.7
0.47
26
241
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
65.0
—
0
9
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
8
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
15
0.00
0.41
0.0
1.5
—
3.6
—
0
10
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(4027681)
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
106
1.34
0.40
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
148
0.73
0.39
4.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
67
1.35
0.38
1.3
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
65
586
1.14
0.38
4.5
4.0
estimate
0.0
0.0
0.00
25
170
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
125
1.30
0.37
1.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
282
1.19
0.37
1.7
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
82
752
1.12
0.37
2.9
3.2
mg/l
30.7
140.0
0.70
53
489
(3019225) pH of Specimen
26
217
1.22
0.37
4.2
3.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
157
0.75
0.37
2.4
2.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
134
0.74
0.35
3.1
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
200
0.79
0.35
2.6
1.8
nmol/l
320.6
378.9
0.62
16
182
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
978
0.90
0.34
3.0
3.7
ng/l
21.6
43.2
3.46
66
698
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
255
2496
1.15
0.33
13.1
8.8
u/l
27.9
25.6
1.20
245
2392
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
99
0.70
0.31
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
53
1.33
0.31
2.9
2.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
206
0.81
0.30
4.4
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
85
796
1.09
0.26
3.6
3.9
mg/mmol
4.9
30.0
0.59
57
507
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
142
1.21
0.25
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
75
1.21
0.25
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
76
1.19
0.25
1.1
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
229
2338
0.91
0.24
4.2
4.6
mmol/l
4.6
4.6
0.15
210
2151
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
81
0.74
0.24
1.5
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
22
190
1.17
0.23
3.6
2.3
ml/min/173m2
61.4
61.9
—
8
70
(3009508) Creatinine [Moles/volume] in Urine
84
791
1.09
0.23
2.9
3.1
mmol/l
7.7
7.8
0.01
74
666
(3049717) Cytology report of Urine Cyto stain
10
79
1.28
0.22
1.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
144
1.19
0.22
1.8
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
181
1758
1.07
0.22
3.6
3.7
pmol/l
15.0
14.9
0.10
164
1581
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
16
188
0.84
0.22
3.9
4.0
ng/l
89.4
81.0
0.19
16
170
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
228
2324
0.92
0.21
4.4
4.7
mmol/l
5.9
6.0
0.66
208
2103
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
227
2314
0.92
0.21
4.1
4.6
mmol/l
1.4
1.5
1.63
207
2112
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
9.2
—
0
11
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
16.1
—
880.7
—
0
11
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
26.4
—
1604.2
—
0
11
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
217.3
—
0
11
(3004959) Base excess in Arterial cord blood by calculation
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.8
—
23.5
—
0
11
(3028433) Virus identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
43
1.17
0.21
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
54
501
1.10
0.21
1.8
1.7
mg/l
1.1
1.1
0.05
43
381
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
48
1.26
0.20
1.2
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
48
1.26
0.20
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
50
539
0.91
0.20
3.7
3.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
497
0.91
0.19
3.5
3.9
ng/l
28.5
365.1
1.92
36
399
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
309
1.11
0.19
8.2
6.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
96
916
1.07
0.19
2.2
2.3
nmol/l
77.1
78.0
0.12
88
803
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
52
1.16
0.19
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
100
1.21
0.18
1.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
263
2598
1.10
0.18
25.7
18.5
e12/l
4.5
4.5
0.12
257
2507
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
195
1.14
0.18
2.3
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
16
138
1.17
0.18
1.1
1.2
u/ml
286.2
167.7
0.41
16
122
(3010813) Leukocytes [#/volume] in Blood
263
2599
1.10
0.17
25.7
18.5
e9/l
7.2
6.7
0.45
257
2510
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
223
2191
1.07
0.17
17.7
11.4
ml/min/173m2
81.3
78.2
1.48
197
1752
(3026493) Urate [Moles/volume] in Serum or Plasma
58
616
0.93
0.17
2.7
2.4
umol/l
343.5
8664.6
3.16
51
535
(3020891) Body temperature
12
101
1.20
0.17
2.8
4.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
91
871
1.06
0.16
4.8
3.8
ug/l
2.5
2.0
0.56
79
767
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
254
1.11
0.16
1.3
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
65
684
0.94
0.15
2.9
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
150
0.86
0.15
1.2
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
86
0.81
0.15
1.3
1.1
—
—
—
0
0
(3000492) Spirometry study
23
208
1.11
0.14
1.7
1.4
—
—
—
0
0
(1002224) Polysomnography panel
8
96
0.83
0.14
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
148
0.87
0.13
1.4
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
85
1.18
0.12
1.1
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
114
1108
1.05
0.12
3.5
3.7
estimate
0.0
0.0
0.00
26
175
(3007461) Platelets [#/volume] in Blood
262
2596
1.07
0.12
25.7
18.5
e9/l
246.6
246.7
0.00
256
2516
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
318
1.08
0.11
5.6
4.8
%
33.2
32.6
0.13
24
206
(3048689) Calprotectin [Mass/mass] in Stool
22
239
0.91
0.11
2.0
2.3
ug/g
95.4
158.6
0.90
22
187
(3009542) Hematocrit [Volume Fraction] of Blood
212
2092
1.05
0.10
19.4
13.7
%
39.9
40.0
0.07
144
1456
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
125
1.13
0.10
4.0
3.2
pmol/l
4.5
4.8
0.64
14
111
(3044290) Cell count panel - Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
45
1.11
0.10
1.6
1.6
%
51.8
62.8
—
5
45
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
370
0.94
0.09
1.3
1.3
u/ml
1.1
6.9
1.62
12
147
(40768797) Stomach Pathology biopsy report
33
311
1.07
0.09
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
79
815
0.96
0.09
2.8
3.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
89
866
1.04
0.09
3.9
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
222
2243
0.96
0.08
3.7
4.2
mmol/l
1.4
1.3
1.44
203
2033
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
58
1.04
0.08
1.0
1.3
—
54.1
—
0
5
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
61
0.82
0.08
7.4
1.2
—
1.0
—
0
5
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
60
0.83
0.08
1.0
1.2
—
15.2
—
0
7
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
63
0.79
0.08
1.0
1.2
—
1.1
—
0
5
(3003327) Ova and parasites identified in Stool by Light microscopy
5
63
0.79
0.08
2.2
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
64
0.78
0.08
7.8
1.3
mg/l
27.5
30.5
—
5
55
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
64
0.78
0.08
7.8
1.3
mg/l
39.9
43.8
—
5
56
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
71
0.84
0.07
1.0
1.2
—
2.5
—
0
11
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
78
1.03
0.07
1.7
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
85
0.82
0.07
1.1
1.2
—
0.2
—
0
6
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
212
2140
0.97
0.07
4.4
4.6
mu/l
1.8
2.5
0.66
195
1928
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
93
0.86
0.07
1.1
1.7
—
180.0
—
0
5
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
80
782
1.03
0.06
2.4
3.0
ng/l
1438.0
1406.2
0.02
75
664
(3041096) Erythrocytes [Presence] in Urine by Automated
61
594
1.03
0.05
3.4
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
68
695
0.97
0.05
3.4
3.7
%
21.3
23.9
0.74
35
317
(3009261) Glucose [Presence] in Urine by Test strip
114
1124
1.02
0.04
3.5
3.7
estimate
0.0
0.0
0.50
24
168
(3021601) Nitrite [Presence] in Urine by Test strip
112
1106
1.02
0.03
4.4
5.0
estimate
0.0
0.0
0.00
24
168
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
122
1.07
0.02
1.2
3.0
e6/l
0.3
0.2
0.07
13
116
(3000494) Fungus identified in Specimen by Culture
28
271
1.04
0.02
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
58
586
0.99
0.00
2.1
2.1
mg/l
3.0
3.0
0.01
50
496
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
122
0.98
0.00
2.4
2.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
58
581
1.00
0.00
1.4
1.5
nmol/l
23.6
21.4
0.36
51
495
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
485
1.01
0.00
2.6
2.6
ug/l
0.6
0.7
0.94
34
313
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
325
0.98
0.00
1.2
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
100
1003
1.00
0.00
1.9
2.0
pmol/l
101.6
94.2
0.84
58
501
(3012544) pH of Venous blood
24
236
1.02
0.00
2.5
3.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
56
0.89
0.00
1.4
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
11.6
—
0.8
—
0
9
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
5.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
173.0
—
0
5
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
57
0.88
0.00
1.4
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
55
0.91
0.00
1.4
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
0.5
—
0
5
(3024928) Oxygen saturation in Venous blood
5
58
0.86
0.00
1.6
2.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
57
0.88
0.00
1.4
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
7.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
17.1
—
0
6
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.1
—
1.2
—
0
8
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
59
0.84
0.00
1.6
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
78
0.89
0.00
1.1
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
60
600
1.00
0.00
1.6
1.6
mmol/l
1.4
1.4
0.05
52
490
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
68.8
—
0
6
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
22.7
—
0
8
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.0
—
2.8
—
0
8
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_FIBROSARCOMA_EXALLC – Fibrosarcoma, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).